Global Women’s Health Market is valued at 31.44 USD Billion in 2018 and expected to reach 44.31 USD Billion by 2025 with the CAGR of 6.13% over the forecast period.
Growing elderly population of women, increasing instances of chronic diseases among women, initiatives by government for population control, and rising demand for contraceptive pills are the major factors for driving the growth of Global Women’s Health Market.
Two Novartis AG women healthcare brands acquired by Torrent Pharma
May 9th, 2017; Torrent Pharma, headquartered in Ahmedabad, has finalized the acquisition of the Indian female health care brands Regestrone and Pregachieve from the Swiss pharmaceutical giant Novartis. Although the company has not disclosed the size of the transaction, it is estimated to be close to Rs 500 crore. Both brands are issued by gynecologists to deal with abnormal uterine bleeding, perimenopausal and postmenopausal symptoms, and infertility. Torrent is an important player in the field of dermatology. It is now considering developing its own business in other key therapies, and acquisitions of small brands could play a key role.
Women’s health includes all treatments, drugs and surgical products for various diseases related to the group of women. These diseases include nutrition, oncology, reproduction, menopause, urology and other health care applications. Women’s health aims to better manage disease and improve women’s overall health. Many governments are increasing their investments to publicize women’s health.
Global Women’s Health Market is segmented on the basis of device, drugs, application, treatment, and vertical. On the basis of device, the market is segmented into implants, intra-uterine devices, female condoms, vaginal rings, pharmaceutical pipeline and others. On the basis of drugs, market is segmented into prolia, nuvaring, premarin, actonel, mirena, EVISTA, FORTEO, and others. On the basis of application, the market is segmented into endometriosis, hormonal infertility, menopause, polycystic ovary syndrome, contraceptives, osteoporosis and others. On the basis of treatment, the market is segmented into hormonal therapies, non-hormonal therapies and surgeries. On the basis of vertical, the market is segmented into hospitals, medical centers, gynecology centers, clinics, research institutes and others.
The regions covered in this Women’s Health market report are North America, Europe, Asia Pacific and rest of the World. On the basis of country level, market ofWomen’s Health is subdivided into U.S., Mexico, Canada, U.K., Germany, France, Italy, China, Japan, South East Asia, Africa, etc.
Key Players Women’s Health Market Report-
Women’s Health Market report covers major key players in the market like Novartis AG, Eli Lilly and Company, Merck & Co., Inc.,Pfizer Inc., Novo Nordisk A/S,Lupin Pharmaceuticals, Inc.,Amgen Inc.,Sanofi, Johnson & Johnson Services, Inc.,AstraZeneca, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Bayer AG,Blairex Laboratories, Inc., Theramex, Agile Therapeutics and others.
GlobalWomen’s Health Market Dynamics-
Growing elderly population of women, increasing instances of chronic diseases, like postmenstrual osteoporosis among women, initiatives by government for population control, and rising demand for contraceptive pills to avoid unwanted pregnancies are the major factors for driving the growth of Global Women’s Health Market. Based on the statistics, around 49.2% of women are likely to possess more than three critical chronic health conditions as compared to men with over 37.5%. Also, the risk of dying for women is 7 times greater when on birth control pills. Such pills are known to develop breast cancers in 1 out of every 20 women in US.
There are increasing efforts into research and development (R&D) of drugs, treatments, methods and diagnosis of all the ailments related to women’s health. Producers are trying to come up with solutions that mitigate side-effects, are less cumbersome and possess negligible post-treatment implications. This is expected to offer lucrative opportunities for the growth of women’s health market.
North America is expected to remain a dominant region in the Global Women’s Health Market.
North America is the dominant region in the market with the largest share of the global Women’s Health market, owing to increasing attention towards women’s therapeutics, growing investments in research and development of new treatments, methods and drugs for with better safety measures for women, rising encountered cases of cancer, along with the presence of world’s best recognized and eminent medical centres and hospitals are believed to be the reasons for the regions dominance in women’s health market. As per National Vital Statistical Reports (NVSS), around
Global Women’s Health Market Segmentation: –
- Intra-uterine devices
- Female condoms
- Vaginal rings
- Pharmaceutical pipeline
- Hormonal infertility
- Polycystic ovary syndrome
- Hormonal therapies
- Non-hormonal therapies
- Medical centers
- Gynecology centers
- Research institutes
By Regional Analysis:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Full Research Report@ https://brandessenceresearch.com/heavy-industry/women-s-health-market-size
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.